These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 6386354

  • 21. [Long-term treatments for systemic sclerosis: what are the perspectives?].
    Mouthon L, Agard C, Garcia De La Peña-Lefebvre P, Guillevin L.
    Ann Med Interne (Paris); 2002 Jun; 153(4):265-75. PubMed ID: 12218893
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H, Tausch G, Eberl R.
    Wien Klin Wochenschr; 1976 Apr 30; 88(9):292-5. PubMed ID: 973388
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Current therapy of systemic sclerosis (scleroderma).
    Müller-Ladner U, Benning K, Lang B.
    Clin Investig; 1993 Apr 30; 71(4):257-63. PubMed ID: 8471811
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of scleroderma and dermatomyositis in childhood].
    Ansell BM.
    Clin Ter; 1978 Jan 31; 84(2):123-31. PubMed ID: 648095
    [No Abstract] [Full Text] [Related]

  • 26. [Scleroderma: Pathogenesis, pathophysiology, and therapy].
    Imai H, Suzuki K.
    Nihon Rinsho; 2006 Feb 31; 64 Suppl 2():446-9. PubMed ID: 16523931
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of generalized (progressive) scleroderma].
    Balda BR.
    Dtsch Med Wochenschr; 1972 Dec 01; 97(48):1876-8. PubMed ID: 4117979
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Physiopathology and therapy of progressive systemic sclerosis].
    Kondo H.
    Nihon Naika Gakkai Zasshi; 1998 Mar 10; 87(3):412-6. PubMed ID: 9577567
    [No Abstract] [Full Text] [Related]

  • 31. Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.
    Baron M, Skrinskas G, Hyland R, Urowitz MB.
    Br Heart J; 1982 Sep 10; 48(3):304-5. PubMed ID: 7201844
    [No Abstract] [Full Text] [Related]

  • 32. Diagnosis and treatment of scleroderma.
    Adnan ZA.
    Acta Med Indones; 2008 Apr 10; 40(2):109-12. PubMed ID: 18560030
    [Abstract] [Full Text] [Related]

  • 33. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis.
    Kamata Y, Kamimura T, Iwamoto M, Minota S.
    Clin Exp Dermatol; 2005 Jul 10; 30(4):451. PubMed ID: 15953103
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Captopril vs. nifedipine.
    Cases A, Bosch X, Campistol JM, Botey A, Revert L.
    Clin Nephrol; 1987 May 10; 27(5):269. PubMed ID: 3297441
    [No Abstract] [Full Text] [Related]

  • 36. Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis.
    Akesson A, Wollheim FA, Thysell H, Gustafson T, Forsberg L, Pahlm O, Wollmer P, Akesson B.
    Scand J Rheumatol; 1988 May 10; 17(5):313-23. PubMed ID: 3212403
    [Abstract] [Full Text] [Related]

  • 37. [Collagen diseases. On clinical aspects and theapy of disseminated lupus erythematosus, progressive scleroderma and dermatomyositis].
    Günther R, Boros A.
    Hippokrates; 1969 Aug 31; 40(16):626-34. PubMed ID: 5810176
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Photochemotherapy in systemic sclerosis. The stage is set.
    Trentham DE.
    Arch Dermatol; 1992 Mar 31; 128(3):389-90. PubMed ID: 1550373
    [No Abstract] [Full Text] [Related]

  • 40. Management of systemic sclerosis--a review.
    Ng SC, Clements PJ, Paulus HE.
    Singapore Med J; 1990 Jun 31; 31(3):269-72. PubMed ID: 2203150
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.